Lucid Tala vs MDHearing Volt

The Lucid Tala is a premium OTC hearing aid priced at $1,300, earning an A grade with a SoundScore of 4.6/5 in our lab testing. This places it among the top performers in the OTC category, ranking #4 out of 65 tested devices. Speech performance stands out as the Tala's defining strength. Speech in quiet scores an excellent 4.6/5, measuring 1.85 points above the OTC category average. Speech in noise also performs well at 3.0/5, exceeding the category average by 1.56 points—a meaningful advantage for conversations in challenging environments. Music streaming delivers solid results at 3.0/5, outpacing the category average by 1.08 points. The Tala does show limitations in feedback handling, scoring 1.7/5 in our tuned testing—2.84 points below the category average. This is a notable weakness that prospective buyers should consider, particularly if prone to feedback-inducing situations. Own-voice comfort scores 2.6/5, which is above the category average but only mixed in absolute terms. This visible-in-ear style device features rechargeable batteries and supports streaming from both iPhone and Android devices with hands-free capability. The Tala has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024. It's best suited for users who prioritize speech clarity and are willing to invest in a premium OTC option, though those particularly sensitive to feedback may want to explore alternatives.

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.